Edition:
United Kingdom

Caladrius Biosciences Inc (CLBS.OQ)

CLBS.OQ on NASDAQ Stock Exchange Capital Market

4.97USD
16 Jan 2019
Change (% chg)

-- (--)
Prev Close
$4.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,170
52-wk High
$11.65
52-wk Low
$3.15

Select another date:

Mon, Oct 22 2018

BRIEF-Roche Says Phase III Study On Alecensa Meets Primary Endpoint

* SAYS WILL TO ANNOUNCE RESULTS FROM THE PHASE III ALESIA STUDY, SHOWING THAT ALECENSA® (ALECTINIB) MET ITS PRIMARY ENDPOINT OF INVESTIGATOR-ASSESSED (INV) PROGRESSION-FREE SURVIVAL (PFS)

Select another date: